Company Profile

ProstaLund AB is a Sweden-based company that provides health care products and services. The Company develops and manufactures urological devices and treatments primarily for benign prostatic hyperplasia (BPH). The Company develops CoreTherm, a patented Thermotherapy treatment method for BPH, which takes approximately 6-15 minutes and offers long-term symptom relief. CoreTherm is used in hospitals and clinics in Sweden and worldwide.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

24/10/25	ProstaLund AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
13/10/25	ProstaLund applies for delisting from Nasdaq Stockholm	RE
16/09/25	ProstaLund takes out loan of SEK 4 mln from two largest shareholders	RE
12/09/25	ProstaLund to Launch Products in UAE, Oman via XEN Group Partnership	MT
12/09/25	ProstaLund enters collaboration agreement with The XEN Group	RE
12/09/25	ProstaLund Enters Collaboration Agreement with the XEN Group for the Market in the United Arab Emirates and Oman	CI
10/09/25	ProstaLund Partners with Dutch Distributor for Benelux Market	MT
10/09/25	ProstaLund enters collaboration with Mayumana Healthcare	RE
10/09/25	Prostalund Enters Collaboration Agreement with Mayumana Healthcare for the Benelux Market	CI
21/08/25	ProstaLund AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
15/07/25	ProstaLund says co has liquidity shortage, seeks new financing	RE
11/07/25	ProstaLund to apply for delisting from Nasdaq First North	RE
26/06/25	Prostalund AB Announces First Coretherm Eagle Treatments Performed in Denmark	CI

24/10/25	PROSTALUND AB (publ) - Interim report January-September 2025	AQ
12/09/25	ProstaLund enters collaboration agreement with the XEN Group for the market in the United Arab Emirates and Oman	AQ
10/09/25	ProstaLund enters collaboration agreement with Mayumana Healthcare for the Benelux market	AQ
21/08/25	ProstaLund AB - Interim Report January-June 2025	AQ
26/06/25	First CoreTherm® Eagle treatments performed in Denmark	AQ

Manager	Title	Age	Since
Malin Melander CEO	Chief Executive Officer	49	31/05/2025
Annette Colin Lövgren DFI	Director of Finance/CFO	61	31/05/2025
Johan Laven SAM	Sales & Marketing	53	01/01/2024

Director	Title	Age	Since
Marianne Östlund BRD	Director/Board Member	62	01/01/2020
Mats Alyhr CHM	Chairman	42	01/06/2025
Allan Jakobsson BRD	Director/Board Member	75	01/06/2025

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PROSTALUND AB	-35.15%	-30.97%	-	-	717K
ABBOTT LABORATORIES	+0.95%	+4.00%	-16.51%	+4.14%	188B
MEDTRONIC PLC	+1.17%	+4.80%	-2.59%	+8.26%	114B
CENCORA, INC.	+2.74%	+8.62%	+14.44%	+77.55%	62.02B
HOYA CORPORATION	+2.38%	+3.92%	+35.52%	+60.21%	55.26B
BECTON, DICKINSON AND COMPANY	+0.59%	+6.52%	-5.86%	-35.81%	48.93B
DEXCOM, INC.	+2.17%	+2.81%	+14.81%	-19.97%	33.08B
MEDLINE INC.	+3.58%	-16.42%	-	-	29.66B
WEST PHARMACEUTICAL SERVICES, INC.	-0.26%	+0.85%	+46.36%	-10.89%	24.78B
TERUMO CORPORATION	+8.53%	+11.42%	-5.85%	+18.17%	23.91B
Average	-1.34%	+3,263.60%	+10.04%	+12.71%	64.45B
Weighted average by Cap.	+1.73%	+2,681.73%	+1.22%	+13.83%

ProstaLund AB Stock

Stocks

PLUN

SE0023468418

Medical Equipment, Supplies & Distribution

Chart: ProstaLund AB

Latest news : ProstaLund AB

Press Releases: ProstaLund AB

Quotes and Performance

Managers and Directors: ProstaLund AB

Other Medical Equipment, Supplies & Distribution

Company Profile